Cargando…
Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A(2) and secretory phospholipase A(2) in patients with newly diagnosed type 2 diabetes
BACKGROUND: China has the highest absolute disease burden of diabetes worldwide. For diabetic patients, diabetes-related vascular complications are major causes of morbidity and mortality. The roles of lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) and secretory phospholipase A(2) (sPLA(2)) a...
Autores principales: | Lin, Xiu-hong, Xu, Ming-tong, Tang, Jv-ying, Mai, Li-fang, Wang, Xiao-yi, Ren, Meng, Yan, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120429/ https://www.ncbi.nlm.nih.gov/pubmed/27881128 http://dx.doi.org/10.1186/s12944-016-0368-3 |
Ejemplares similares
-
Secretory Phospholipase A2s in Insulin Resistance and Metabolism
por: Kuefner, Michael S.
Publicado: (2021) -
Secretory Phospholipases A(2) in Plants
por: Mariani, María Elisa, et al.
Publicado: (2019) -
Biology of Secretory Phospholipase A(2)
por: Boyanovsky, Boris B., et al.
Publicado: (2008) -
Plasma Lipoprotein-associated Phospholipase A2 in Patients with Metabolic Syndrome and Carotid Atherosclerosis
por: Gong, Hui-ping, et al.
Publicado: (2011) -
Elevated Type II Secretory Phospholipase A2 Increases the Risk of Early Atherosclerosis in Patients with Newly Diagnosed Metabolic Syndrome
por: Sun, Chang-Qing, et al.
Publicado: (2016)